DSIP (Delta Sleep-Inducing Peptide)
What Adrenalectomy Changed
Bjartell and colleagues examined immunoreactive delta sleep-inducing peptide in the rat hypothalamus, pituitary and adrenal gland, and the effects of adrenalectomy, published in Hormone Research in 1991. Those three tissues form a single regulatory axis, and removing the adrenals tests whether a substance is part of it.
Key facts
- Study
- Bjartell 1991 (PMID 1814802)
- Journal
- Horm Res
- Tissues
- Hypothalamus, pituitary, adrenal gland
- Intervention
- Adrenalectomy
- Measured as
- Immunoreactive DSIP
- Axis implicated
- Hypothalamic-pituitary-adrenal
Why those three tissues together
Hypothalamus, pituitary and adrenal gland form a single regulatory axis. The hypothalamus signals the pituitary, the pituitary signals the adrenal, and adrenal hormones feed back on both. Measuring across all three treats them as one system rather than three separate sites.
Why removing the adrenals is an informative intervention
Adrenalectomy removes the feedback arm. Without adrenal steroids returning to the brain and pituitary, the upstream parts of the axis change their output substantially. Anything that moves in response is connected to that regulation, and anything that does not is probably independent of it.
Research material referenced
DSIP 5mg — third-party HPLC tested
What the design can establish
Whether the measured immunoreactivity behaves like a component of the axis. A substance responding to adrenalectomy is regulated alongside the axis; one that does not is unrelated to it. It is a clean question, and it does not require knowing what the substance is.
The caveat that applies throughout
The measurement is immunoreactivity, and the paper's title says so. Given that Graf and Kastin had already shown peripheral immunoreactive material was mostly larger than DSIP, what moves in response to adrenalectomy may or may not be the nine-residue peptide. The observation stands; the attribution is less certain than the compound's name implies.
Why the adrenal connection is worth noting anyway
Because it recurs. The hypothalamic-pituitary-adrenal axis governs the stress response and follows a strong daily rhythm, and a substance tracking it would have a plausible route to sleep-related observations without acting on sleep directly. Correlation with a circadian system is not the same as a sleep mechanism.
Regulatory position
DSIP holds no marketing authorisation from the MHRA, EMA or FDA. Material supplied here is for laboratory research only, and no claim is made about sleep, stress, hormones or any condition in any person.
Extended research context
The DSIP (Delta Sleep-Inducing Peptide) deep dive
Deep dive: a name that was a hypothesis, not a finding
In 1977 the Schoenenberger-Monnier group in Basel electrically stimulated the thalamus of a sleeping rabbit, collected blood draining from its brain, isolated a peptide fraction, and reported that administering it into the ventricles of awake rabbits produced delta-wave EEG activity. They named it delta sleep-inducing peptide. By the standards of the time this was careful, imaginative work, and they followed it properly - the 1978 Pflugers Archiv paper reported sequence, synthesis and activity of the synthetic nonapeptide rather than stopping at a suggestive fraction. The problem is not the original research. It is that a name recording a hypothesis has been read ever since as a summary of established pharmacology, and almost nobody checks whether it was earned.
Deep dive: the three things that are missing
A proposed endogenous peptide becomes accepted biology by a recognisable route. The gene is located. The precursor protein is characterised. A receptor is identified, giving a mechanism and a testable target. DSIP has completed none of these in nearly fifty years. The receptor gap is the most disabling - without one there is no mechanism to test, no dose-response to build, no antagonist to design, and no way to establish that an observed effect runs through the proposed pathway at all. The gene gap is the hardest to explain away: modern genomics located MOTS-c inside a short open reading frame nested within the mitochondrial 12S rRNA gene, sequence already annotated as something else. That a peptide described in 1977 still has no identified gene in any genome is a substantive observation, not an accident of effort.
Deep dive: why 519 papers is not 519 confirmations
DSIP has roughly 519 indexed PubMed records - more than Selank's 135 or Semax's 231. Publication volume tracks how interesting a question is, not how well it has been answered. A tractable question generates a burst of work and then stops; a question that resists resolution generates papers indefinitely, each a further attempt rather than a further confirmation. Kovalzon's 2006 review in the Journal of Neurochemistry states the field's own assessment in its title: a still unresolved riddle. Reading any individual DSIP paper without that context invites mistaking activity for consensus.
Research applications
- ▸Historical study of humoral sleep-factor hypotheses
- ▸Electroencephalography and delta-wave research methodology
- ▸Structure-activity work on flexible, acidic short peptides
- ▸Comparative work on peptides lacking identified receptors
- ▸Analytical method development for tryptophan-containing peptides
Handling checklist
- ✓Store lyophilised material cold, dry and protected from light
- ✓No reducing agent needed — the sequence contains no cysteine
- ✓No methionine oxidation to expect; a +16 Da satellite warrants explanation
- ✓Protect from prolonged light — the single tryptophan is mildly photosensitive
- ✓Expect pH-dependent solubility; the peptide is strongly acidic with no basic residue
- ✓Aliquot to avoid repeated freeze-thaw cycles
Common research-handling mistakes
Learnt from thousands of researcher orders across our UK labs.
✗ Treating the name as evidence of the effect
Fix: The name records a 1977 hypothesis from a single rabbit EEG study. It is not a summary of established pharmacology.
✗ Citing the 1977 paper as proof DSIP induces sleep
Fix: It reports delta-wave EEG activity in rabbits after intraventricular administration — a narrower claim than inducing sleep, in one species, by a route that bypasses every normal barrier.
✗ Assuming DSIP is an established endogenous human peptide
Fix: No gene has been identified in any species, no precursor characterised and no receptor found.
✗ Reading 519 papers as 519 confirmations
Fix: Volume reflects an unresolved question attracting sustained attempts, not accumulated confirmation.
✗ Making any sleep claim about supplied material
Fix: The evidence does not support it and a therapeutic claim about research material is what MHRA enforcement targets.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Related questions researchers ask
- What is DSIP?
- Does DSIP actually induce sleep?
- How was DSIP discovered?
- Does DSIP have a receptor?
- What are delta waves?
- Is DSIP approved anywhere?
Frequently asked questions
- Why examine hypothalamus, pituitary and adrenal together?
- They form one regulatory axis with feedback between them, so measuring across all three treats them as a system.
- What does adrenalectomy test?
- It removes the feedback arm, so anything responding is connected to that regulation and anything unchanged is probably independent.
- Was DSIP itself measured?
- Immunoreactive DSIP, per the paper's own title — which does not establish that the nine-residue peptide was what moved.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedBjartell A et al., Immunoreactive delta sleep-inducing peptide in the rat hypothalamus, pituitary and adrenal gland: effects of adrenalectomy — Horm Res 1991 (PMID 1814802)pubmed.ncbi.nlm.nih.gov
- PubMedGraf MV, Kastin AJ — Proc Soc Exp Biol Med 1984 (PMID 6548030)pubmed.ncbi.nlm.nih.gov
- PubMedGimble JM et al., Delta sleep-inducing peptide and glucocorticoid-induced leucine zipper: potential links between circadian mechanisms and obesity? — Obes Rev 2009 (PMID 19849801)pubmed.ncbi.nlm.nih.gov
- PubMedSchoenenberger GA et al., Characterization of a delta-EEG (sleep)-inducing peptide — PNAS 1977 (PMID 265572)pubmed.ncbi.nlm.nih.gov
- PubMedSchoenenberger GA et al., DSIP XI: amino-acid analysis, sequence, synthesis and activity — Pflugers Arch 1978 (PMID 568769)pubmed.ncbi.nlm.nih.gov
- PubMedKovalzon VM, Delta sleep-inducing peptide (DSIP): a still unresolved riddle — J Neurochem 2006 (PMID 16539679)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Delta sleep-inducing peptide (CID 68816)pubchem.ncbi.nlm.nih.gov
- PubMedPubMed — DSIP literaturepubmed.ncbi.nlm.nih.gov
- RefMHRA — Medicines and Healthcare products Regulatory Agencygov.uk
- GuidelineGoogle — Creating helpful, reliable, people-first contentdevelopers.google.com
Written and reviewed by
Jack Muncaster · Founder, UK Peptides
Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.
More DSIP (Delta Sleep-Inducing Peptide) articles
- A Question Mark in the Title Is Doing Real WorkGimble 2009 proposed links between DSIP, glucocorticoid-induced leucine zipper, circadian mechanisms and obesity — and framed it as a question.
- What the Field Said After Its First DecadeGraf published a DSIP update in Peptides in 1986. Reading a review from the middle of a literature shows what was expected but never arrived.
- The Barrier Any Central Claim Has to CrossA compound said to act on sleep must reach the brain. The blood-brain barrier excludes most peptides, and getting across is an engineering problem.
- What Is DSIP? A Research OverviewDSIP is a nonapeptide isolated from rabbit blood in 1977 and named for an observed EEG effect. No gene, precursor or receptor has ever been identified.
- Does DSIP Actually Induce Sleep? What the Evidence ShowsDSIP is named for a sleep effect. The evidence has never firmed up: no gene, no receptor, and a literature its own reviewers call an unresolved riddle.
Popular across the research hub
One flagship guide from every other research category — keep exploring.
- Retatrutide ResearchRetatrutide Peptide Structure
- GHK-Cu (Copper Peptide)GHK-Cu Molecular Weight, and Why Published Figures Differ
- TB-500 (Thymosin β4 fragment)TB-500 Molecular Weight, and the Figure That Is Wrong
- BPC-157 (Pentadecapeptide)BPC-157 in the Published Literature
- CJC-1295 & IpamorelinCJC-1295 With and Without DAC
- Peptide ReferencePeptides: A Complete Reference Guide
- Bacteriostatic WaterBacteriostatic Water for Reconstitution
- Research & Regulatory NewsTRIUMPH-6: Maintenance of Weight Reduction
- GLP-1 & Incretin ScienceWhat Is Exenatide? From Gila Monster Venom to Medicine
- MOTS-c (Mitochondrial Peptide)MOTS-c Structure, Sequence and Physical Properties
- Semax (ACTH Fragment Peptide)Semax Structure, Sequence and Physical Properties
- Selank (Tuftsin Analogue)Selank's Enkephalinase Mechanism
- KLOW (Blend)The Fourth Component: What KPV Actually Adds
- GLOW (Blend)Why the Copper Question Has a Good Answer Here
- MT-2 (Melanotan II)The Pharmacology Works. This Compound Was Not Developed.
- IGF-1 LR3Two Hormones, One Feedback Loop
- GlutathioneAn Enzyme Family That Uses Glutathione as a Reagent
- NAD+DNA Damage Draws Down the Pool
- KPVAlpha-MSH: Pigmentation and Inflammation in One Hormone